Publications

Molecular Alterations in Meningioangiomatosis Causing Epilepsy. Dono A, Alfaro-Munoz K, Yan Y, Lopez-Garcia CA, Soomro Z, Williford G, Takayasu T, Robell L, Majd NK, de Groot J, Esquenazi Y, Kamiya-Matsuoka C, Ballester LY. Neurosurgery. 2022 Feb 22. doi: 10.1227/NEU.0000000000001875. PMID: 35179134.

Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma. Dono A, Zhu P, Holmes E, Takayasu T, Zhu JJ, Blanco AI, Hsu S, Bhattacharjee MB, Ballester LY, Kim DH, Esquenazi Y, Tandon N. J Neurooncol. 2022 Jan;156(2):353-363. doi: 10.1007/s11060-021-03917-1. Epub 2022 Jan 8. PMID: 34997451.

Hormone exposure and its suppressive effect on risk of high-grade gliomas among patients with breast cancer. Lopez-Garcia CA, Lopez-Rivera V, Dono A, Salazar-Marioni S, Novo JE, Sheth SA, Ballester LY, Esquenazi Y. Clin Neurosci. 2021 Dec;94:200-203. doi: 10.1016/j.jocn.2021.10.029. Epub 2021 Nov 2.PMID: 34863438

Molecular Alterations in Meningioangiomatosis Causing Epilepsy. Dono A, Pothiawala AZ, Lewis CT, Bhattacharjee MB, Ballester LY, Tandon N. Neuropathol Exp Neurol. 2021 Nov 19;80(11):1043–1051. doi: 10.1093/jnen/nlab095. Epub 2021 Sep 27. PMID: 34580720.

Geographic landscape of foreign medical graduates in US neurosurgery training programs from 2007 to 2017. Chandra A, Brandel MG, Wadhwa H, Pereira MP, Lewis CT, Haddad YW, Lu VM, Almeida ND, Nuru MO, Esquenazi Y, Aghi MK. Clin Neurol Neurosurg. 2021 Aug 24;209:106891. doi: 10.1016/j.clineuro.2021.106891. Epub ahead of print. PMID: 34492549.

A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma. Khalafallah AM, Rakovec M, Bettegowda C, Jackson CM, Gallia GL, Weingart JD, Lim M, Esquenazi Y, Zacharia BE, Goldschmidt E, Ziu M, Ivan ME, Venteicher AS, Nduom EK, Mamelak AN, Chu RM, Yu JS, Sheehan JP, Nahed BV, Carter BS, Berger MS, Sawaya R, Mukherjee D. Neurosurgery. 2021 Jul 28:nyab257. doi: 10.1093/neuros/nyab257. Epub ahead of print. PMID: 34320218.

The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastoma. Dono A, Ramesh AV, Wang E, Shah M, Tandon N, Ballester LY, Esquenazi Y. Neurooncol Adv. 2021 Mar 31;3(1):vdab050. doi: 10.1093/noajnl/vdab050. PMID: 34131647.

PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma. Dono A, Mitra S, Shah M, Takayasu T, Zhu JJ, Tandon N, Patel CB, Esquenazi Y, Ballester LY. J Neurooncol. 2021 Apr 21. doi: 10.1007/s11060-021-03755-1. Epub ahead of print. PMID: 33881725.

Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma. Dono A, Chandra A, Ballester LY, Esquenazi Y. Neurosurgery. 2021 Apr 7:nyab100. doi: 10.1093/neuros/nyab100. Epub ahead of print. PMID: 33826714.

Role of Ethnicity and Geographic Location on Glioblastoma IDH1/IDH2 Mutations. McCormack RM, Zhu P, Dono A, Takayasu T, Bhatia A, Blanco AI, Tandon N, Ostrom QT, Gonzales A, Moreno S, Ballester LY, Esquenazi Y. World Neurosurg. 2021 Jan 28:S1878-8750(21)00110-8. doi: 10.1016/j.wneu.2021.01.079. Epub ahead of print. PMID: 33516867.

Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma. Dono A, Amsbaugh M, Martir M, Smilie RH, Riascos RF, Zhu JJ, Hsu S, Kim DH, Tandon N, Ballester LY, Blanco AI, Esquenazi Y. J Neurooncol. 2021 Mar;152(1):153-162. doi: 10.1007/s11060-020-03689-0. PMID: 33492602

Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes? Patrizz A, Dono A, Zhu P, Tandon N, Ballester LY, Esquenazi Y. J Neurooncol. 2021 Mar;152(1):163-172. doi: 10.1007/s11060-020-03690-7. PMID: 33481149

Extent of resection and survival outcomes of geriatric patients with glioblastoma: Is there benefit from aggressive surgery? Lopez-Rivera V, Dono A, Lewis CT, Chandra A, Abdelkhaleq R, Sheth SA, Ballester LY, Esquenazi Y. Clin Neurol Neurosurg. 2021 Mar;202:106474. doi: 10.1016/j.clineuro.2021.106474. PMID: 33454497

Variable expression of CXCR4 in molecular subtypes of infiltrating gliomas. Dono A, Zhu P, Zorofchian S, Takayasu T, Quezado MM, Rios A, Powers A, Esquenazi Y, Ballester LY. Clin Neuropathol. 2021 Mar-Apr;40(2):98-107. doi: 10.5414/NP301287. PMID: 33300867

Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies. Shah M, Takayasu T, Zorofchian Moghadamtousi S, Arevalo O, Chen M, Lan C, Duose D, Hu P, Zhu JJ, Roy-Chowdhuri S, Riascos RF, Chen H, Luthra R, Esquenazi Y, Ballester LY. J Mol Diagn. 2021 Feb 23(2):171-180. doi: 10.1016/j.jmoldx.2020.10.013.

Differences in genomic alterations between brain metastases and primary tumors. Dono A, Takayasu T, Yan Y, Bundrant BE, Arevalo O, Lopez-Garcia CA, Esquenazi Y, Ballester LY. Neurosurgery. 2021 Feb 16;88(3):592-602. doi: 10.1093/neuros/nyaa471.PMID: 33369669

Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma. Otani Y, Sur H, Rachaiah G, Namagiri S, Chowdhury A, Lewis CT, Shimizu T, Gangaplara A, Wang X, Vézina A, Maric D, Jackson S, Yan Y, Zhengping Z, Ray-Chaudhury A, Kumar S, Ballester LY, Chittiboina P, Yoo JY, Heiss J, Kaur B, Kumar Banasavadi-Siddegowda Y. Neuro Oncol. 2021 Feb 8:noab014. doi: 10.1093/neuonc/noab014. Epub ahead of print. PMID: 33556161.

Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter? Chandra A, Lopez-Rivera V, Dono A, Brandel MG, Lewis C, O’Connor KP, Sheth SA, Ballester LY, Aghi MK, Esquenazi Y. World Neurosurg.2021 Feb;146:e755-e767. doi: 10.1016/j.wneu.2020.11.003. PMID: 33171326

IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions. Dono A, Ballester LY, Primdahl D, Esquenazi Y, Bhatia A. Curr Oncol Rep. 2021 Jan 25;23(2):20. doi: 10.1007/s11912-020-01006-6. PMID: 33492489.

Predictors of outcome in pleomorphic xanthoastrocytoma. Dono A, Lopez-Rivera V, Chandra A, Lewis CT, Abdelkhaleq R, Sheth SA, Ballester LY, Esquenazi Y. Neuro-Oncology Practice. 2020 Nov 20;8(2):222-229. doi: 10.1093/nop/npaa076. PMID: 33898055.

Glioma and temozolomide induced alterations in gut microbiome. Patrizz A, Dono A, Zorofchian S, Hines G, Takayasu T, Husein N, Otani Y, Arevalo O, Choi HA, Savarraj J, Tandon N, Ganesh BP, Kaur B, McCullough LD, Ballester LY, Esquenazi Y. Sci Rep. 2020 Dec 3;10(1):21002. doi: 10.1038/s41598-020-77919-w. PMID: 33273497.

Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics. Dono A, Takayasu T, Ballester LY, Esquenazi Y. J Clin Neurosci. 2020 Dec; 82 (A): 1-8. doi: 10.1016/j.jocn.2020.10.005

Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma. Li J, Zhao S, Lee M, Yin Y, Li J, Zhou Y, Ballester LY, Esquenazi Y,Dashwood RH, Davies PJA, Parsons DW, Li XN, Huang Y, Sun D. Sci Adv. 2020 Oct 16;6(42):eabb5427. doi: 10.1126/sciadv.abb5427. PMID: 33067228;

Real-time intracranial pressure monitoring during high-dose methotrexate treatment for primary central nervous system lymphoma. Dono A, Husein N, Ybarra C, Hasbun R, Choi HA, Ballester LY, Esquenazi Y. Cancer Treat Res Commun. 2020 Nov 2;25:100234. doi: 10.1016/j.ctarc.2020.100234. PMID: 33161322.

Treatment trends and overall survival in patients with grade II/III ependymoma: The role of tumor grade and location. Lopez-Rivera V, Dono A, Abdelkhaleq R, Sheth SA, Chen PR, Chandra A, Ballester LY, Esquenazi Y. Clin Neurol Neurosurg. 2020 Oct 6;199:106282. doi: 10.1016/j.clineuro.2020.106282.

Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses. Dono A, Vu J, Anapolsky M, Hines G, Takayasu T, Yan Y, Tandon N, Zhu JJ, Bhattacharjee MB, Esquenazi LY, Ballester LY. J Neurooncol. 2020 Oct 3. doi: 10.1007/s11060-020-03634-1.

Ion Channels and Their Role in the Pathophysiology of Gliomas. Takayasu T, Kurisu K, Esquenazi Y, Ballester LY. Mol Cancer Ther. 2020 Oct;19(10):1959-1969. doi: 10.1158/1535-7163.MCT-19-0929.

The Brain is Not Flat: Conformal Electrode Arrays Diminish Complications of Subdural Electrode Implantation, a Series of 117 Cases. Tong BA, Esquenazi Y, Johnson J, Zhu P, Tandon N. World Neurosurg. 2020 Sep 16:S1878-8750(20)32071-4. doi: 10.1016/j.wneu.2020.09.063.

Posttreatment Maturation of Medulloblastoma into Gangliocytoma: Report of 2 Cases. Mullarkey M, Nehme G, Mohiuddin S, Ballester LY, Bhayyacharjee MB, Trivedi D, Shah MN, Fuller GN, Zaky W, Sanberg DI. Pediatr Neurosurg. 2020;1-10. doi:10.1159/000509520.

Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors. Takayasu T, Shah M, Dono A, Yan Y, Borkar R, Putluri N, Zhu JJ, Hama S, Yamasaki F, Tahara H, Sugiyama K, Kurisu K, Esquenazi Y, Ballester LY. Sci Rep. 2020;10(1):14326. Published 2020 Aug 31. doi:10.1038/s41598-020-71161-0.

NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways. Avci NG, Ebrahimzadeh-Pustchi S, Akay YM, Esquenazi Y,Tandon N, Zhu JJ, Akay M. Sci Rep. 2020;10(1):13352. Published 2020 Aug 7. doi:10.1038/s41598-020-70392-5.

Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters. Dono A, Patrizz A, McCormack RM, Putluri N, Ganesh BP, Kaur B, McCullough LD, Ballester LY, Esquenazi Y. CNS Oncol. 2020;9(2):CNS57. doi:10.2217/cns-2020-0007.

Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database. Lu VM, Shah AH, Eichberg DG, Quinones-Hinojosa A, Esquenazi Y, Komotar RJ, Ivan ME. J Neurooncol. 2020;147(3):711-720. doi:10.1007/s11060-020-03480-1.

Microthrombi Correlates With Infarction and Delayed Neurological Deficits After Subarachnoid Hemorrhage in Mice. Dienel A, Ammassam Veettil R, Hong SH, Matsumura K, Kumar T P, Yan Y, Blackburn SL, Ballester LY, Marrelli SP, McCullough LD, McBride DW. Stroke. 2020;51(7):2249-2254. doi:10.1161/STROKEAHA.120.029753.

Molecular characteristics and clinical features of multifocal glioblastoma. Dono A, Wang E, Lopez-Rivera V, Ramesh AV, Tandon N, Ballester LY, Esquenazi Y. J Neurooncol. 2020;148(2):389-397. doi:10.1007/s11060-020-03539-z.

Landscape of Genomic Alterations in IDH Wild-Type Glioblastoma Identifies PI3K as a Favorable Prognostic Factor. Yan Y, Takayasu T, Hines G, Dono A, Hsu SH, Zhu JJ, Riascos-Castaneda RF, Kamali A, Bhattacharjee MB, Blanco AI, Tandon N, Kim DH, Ballester LY, Esquenazi Y. JCO Precision Oncology. 2020;4: 575-584. doi: 10.1200/PO.19.00385.

A direct visuosensory cortical connectivity of the human limbic system. Dissecting the trajectory of the parieto-occipito-hypothalamic tract in the human brain using diffusion weighted tractography. Kamali A, Ghazi Sherbaf F, Rahmani F, Khayat-Khoei M, Aein A, Gandhi A, Shah EG, Sair HI, Riascos RF, Esquenazi Y, Zhu JJ, Keser Z, Hasan KM. Neurosci Lett. 2020;728:134955. doi:10.1016/j.neulet.2020.134955

5-Year-Old Girl with Worsening Seizure Disorder. Iqbal F, Ballester LY, Aakash N, Sandberg DI, Bhattacharjee MB. Brain Pathol. 2020;30(3):717-718. doi:10.1111/bpa.12835.

Endoscopic Third Ventriculostomy for Hydrocephalus Secondary to Extraventricular Obstruction in Thalamic Hemorrhage: A Case Series. Zeineddine HA, Dono A, Kitagawa R, Savitz SI, Choi HA, Chang TR, Ballester LY, Esquenazi Y. Oper Neurosurg (Hagerstown). 2020;opaa094. doi:10.1093/ons/opaa094.

Plasma cfDNA in Glioblastoma-Letter. Takayasu T, Esquenazi Y, Ballester LY. Clin Cancer Res. 2020;26(9):2275. doi:10.1158/1078-0432.CCR-19-4159.

Challenges of Neurosurgery Education During the Coronavirus Disease 2019 (COVID-19) Pandemic: A U.S. Perspective. Lewis CT, Zeineddine HA, Esquenazi Y.World Neurosurg. 2020;138:545-547. doi:10.1016/j.wneu.2020.04.179

High-dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a nonhuman primate model. Sandberg DI, Kharas N, Yu B, Janssen CF, Trimble A, Ballester LY, Patel R, Mohammad AS, Elmquist WF, Sirianni RW.  J Neurosurg Pediatr. 2020;1-9. doi:10.3171/2020.2.PEDS19786.

Increased Risk of Subsequent Meningioma Among Women with Malignant Breast Cancer. Lopez-Rivera V, Zhu P, Dono A, Lee S, Chen PR, Ballester LY, Sheth SA, Esquenazi Y. World Neurosurg. 2020;139:e271-e285. doi:10.1016/j.wneu.2020.03.203.

Geographic and socioeconomic considerations for glioblastoma treatment in the elderly at a national level: a US perspective. Lu VM, Lewis CT, Esquenazi Y. Neurooncol Pract.2020 Jun 3;7(5):522-530. doi: 10.1093/nop/npaa029. PMID: 33014393

Filamin A-negative Hyaline Astrocytic Inclusions in Pediatric Patients with Intractable Epilepsy: Report of 2 Cases. Fischer GM, Vaziri Fard E, Shah MN, Patel RP, Allmen GV, Ballester LY, Bhattacharjee MB. J Neurosurg Pediatr. 2020;1-7. doi:10.3171/2020.1.PEDS19706.

Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion. Ballester LY, Meis JM, Lazar AJ, et al. J Neuropathol Exp Neurol. 2020;79(3):347–351. doi:10.1093/jnen/nlz140.

Impact of facility type and volume in low-grade glioma outcomes. Zhu P, Du XL, Blanco AI, Ballester LY, Tandon N, Berger MS, Zhu JJ, Esquenazi Y. J Neurosurg. 2019;1–11. doi:10.3171/2019.6.JNS19409.

Intracranial Approach for Retrieval of the Condylar Head After Avulsion into the Middle Cranial Fossa.Esquenazi Y, Zeineddine HA, Reimer E, Stackowicz D, Demian N.  World Neurosurg. 2019;130:259–263. doi:10.1016/j.wneu.2019.07.008.

In Reply: Thalamic Glioblastoma: Clinical Presentation, Management Strategies, and Outcomes. Esquenazi Y, Moss N, Tabar V. Neurosurgery. 2019 May 1;84(5):E289-E290. doi: 10.1093/neuros/nyz010.

Cerebral Radiation Necrosis: Incidence, Pathogenesis, Diagnostic Challenges, and Future Opportunities. Ali FS, Arevalo O, Zorofchian S, Patrizz A, Riascos R, Tandon N, Blanco A, Ballester LY, Esquenazi Y. Curr Oncol Rep. 2019 Jun 19;21(8):66. doi: 10.1007/s11912-019-0818-y.

Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases. Ballester LY, Moghadamtousi SZ, Leeds NE, Huse JT, Fuller GN. Acta Neuropathol Commun. 2019 Apr 29;7(1):63. doi: 10.1186/s40478-019-0721-7.

Telomerase reverse transcriptase alterations in human cancers: Diagnosis, prognosis, and therapeutic implications. Esquenazi Y, Ballester LY. Cancer Cytopathol. 2019 Apr 8. doi: 10.1002/cncy.22123.

Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer. Vantaku V, Dong J, Ambati CR, Perera D, Donepudi SR, Amara CS, Putluri V, Ravi SS, Robertson MJ, Piyarathna DWB, Villanueva M, von Rundstedt FC, Karanam B, Ballester LY, Terris MK, Bollag RJ, Lerner SP, Apolo AB, Villanueva H, Lee M, Sikora AG, Lotan Y, Sreekumar A, Coarfa C, Putluri N. Clin Cancer Res. 2019 Mar 7. doi: 10.1158/1078-0432.CCR-18-1515.

Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent Glioblastoma. Morris SL, Zhu P, Rao M, Martir M, Zhu JJ, Hsu S, Ballester LY, Day AL, Tandon N, Kim DH, Shepard S, Blanco A, Esquenazi Y. World Neurosurg. 2019 Apr 4. pii: S1878-8750(19)30873-3. doi: 10.1016/j.wneu.2019.03.193.

Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database. Zhu P, Du XL, Zhu JJ, Esquenazi Y. J Neurosurg. 2019 Feb 15:1-12. doi: 10.3171/2018.10.JNS182247.

EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma. Hovinga KE, McCrea HJ, Brennan C, Huse J, Zheng J, Esquenazi Y, Panageas KS, Tabar V. J Neurooncol. 2019 Apr;142(2):337-345. doi: 10.1007/s11060-019-03102-5.

Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema. Hong B, Muili K, Bolyard C, Russell L, Lee TJ, Banasavadi-Siddegowda Y, Yoo JY, Yan Y, Ballester LY, Bockhorst KH, Kaur B. Mol Ther Oncolytics. 2018 Dec 6;12:93-102. doi: 10.1016/j.omto.2018.11.005.

Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies. Zorofchian S, Iqbal F, Rao M, Aung PP, Esquenazi Y, Ballester LY. J Clin Pathol. 2018 Nov 22. pii: jclinpath-2018-205414. doi: 10.1136/jclinpath-2018-205414.

Neurosurgical Residency Training in Latin America: Current Status, Challenges, and Future Opportunities. Murguia-Fuentes R, Husein N, Vega A, Rangel-Castilla L, Rotta JM, Quinones-Hinojosa A, Guinto G, Esquenazi Y. World Neurosurg. 2018 Sep 11. pii: S1878-8750(18)32041-2. doi: 10.1016/j.wneu.2018.08.232.

Detection of the MYD88 p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma. Zorofchian S, Lu G, Zhu JJ, Duose DY, Windham J, Esquenazi Y, Ballester LY. Front Oncol. 2018 Sep 20;8:382. doi: 10.3389/fonc.2018.00382. eCollection 2018.

Characterization of genomic alterations in primary central nervous system lymphomas. Zorofchian S, El-Achi H, Yan Y, Esquenazi Y, Ballester LY. J Neurooncol. 2018 Aug 31. doi: 10.1007/s11060-018-2990-6.

Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors. Ballester LY, Lu G, Zorofchian S, Vantaku V, Putluri V, Yan Y, Arevalo O, Zhu P, Riascos RF, Sreekumar A, Esquenazi Y, Putluri N, Zhu JJ. Acta Neuropathol Commun. 2018 Aug 31;6(1):85. doi: 10.1186/s40478-018-0588-z.

Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted. Ballester LY, Dunbar E, Guha-Thakurta N, Henson JW, Chandler H, Watkins J, Fuller GN. Front Neurol. 2018 Aug 27;9:700. doi: 10.3389/fneur.2018.00700. eCollection 2018.

Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma. Park AK, Kim P, Ballester LY, Esquenazi Y, Zhao Z. Neuro Oncol. 2018 Jul 25. doi: 10.1093/neuonc/noy120.

Fluciclovine, Anti-1-amino-3-[¹⁸F]-fluorocyclobutane-1-carboxylic acid: A Novel Radiotracer for Meningioma. Nguyen QB, Amato R, Riascos R, Ballester LY, Tandon N, Blanco A, Esquenazi Y. World Neurosurg. 2018 Aug 2. pii: S1878-8750(18)31711-X. doi: 10.1016/j.wneu.2018.07.231.

Planned Gamma Knife Boost After Chemoradiotherapy For Selected Sinonasal And Nasopharyngeal Cancers. Díaz-Martínez JA, Esquenazi Y, Martir M, Citardi MJ, Karni RJ, Blanco AI. World Neurosurg. 2018 Jul 30. pii: S1878-8750(18)31661-9. doi: 10.1016/j.wneu.2018.07.183.

Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma. Park AK, Kim P, Ballester LY, Esquenazi Y, Zhao Z. Neuro Oncol. 2018 Jul 25. doi: 10.1093/neuonc/noy120.

Factors influencing outcome in patients with colloid cysts who present with acute neurological deterioration. Singh H, Burhan Janjua M, Ahmed M, Esquenazi Y, Dhandapani S, Mauer E, Schwartz TH, Souweidane MS J Clin Neurosci. 2018 Aug;54:88-95. doi: 10.1016/j.jocn.2018.06.006. Epub 2018 Jun 12

Primary Central Nervous System Lymphoma with Associated Demyelination and Creutzfeldt Astrocytes. El Achi H, Lally J, Riascos R, Zhu J, Tandon N, Esquenazi Y, Bhattacharjee M, and Ballester LY. Annals of Clinical & Laboratory Science, vol. 48, no. 4, 2018.

Orbital and nasal meningoencephaloceles secondary to chronic hydrocephalus: A rare cause of bilateral proptosis. Jenner ZB, Husein N, Riascos R, Esquenazi Y. Neuroradiol J. 2018 Jan 1:1971400918778145. doi: 10.1177/1971400918778145.

Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease. Ballester LY, Glitza Oliva IC, Douse DY, Chen MM, Lan C, Haydu LE, Huse JT, Roy-Chowdhuri S, Luthra R, Wistuba II, Davies MA. J Neuropathol Exp Neurol. 2018 Jun 4. doi: 10.1093/jnen/nly046.

Cognitive disability in adult patients with brain tumors. Ali FS, Hussain MR, Gutiérrez C, Demireva P, Ballester LY, Zhu JJ, Blanco A, Esquenazi Y. Cancer Treat Rev. 2018 Mar 2;65:33-40. doi: 10.1016/j.ctrv.2018.02.007. Review.

Domain retention in transcription factor fusion genes and its biological and clinical implications. a pan-cancer study. Kim P, Ballester LY, Zhao Z. Oncotarget. 2017 Nov 24;8(66):110103-110117. doi: 10.18632/oncotarget.22653. eCollection 2017 Dec 15.

Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins. Ballester LY, Boghani Z, Baskin DS, Britz GW, Olsen R, Fuller GN, Powell SZ, Cykowski MD. Brain Pathol. 2018 Mar 6. doi: 10.1111/bpa.12604.